ICHOR HOLDINGS LTD (ICHR) Fundamental Analysis & Valuation

NASDAQ:ICHR • KYG4740B1059

Current stock price

64.52 USD
+0.06 (+0.09%)
At close:
64.62 USD
+0.1 (+0.15%)
After Hours:

This ICHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ICHR Profitability Analysis

1.1 Basic Checks

  • In the past year ICHR was profitable.
  • In the past year ICHR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
  • ICHR had a positive operating cash flow in each of the past 5 years.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • With a Return On Assets value of -5.60%, ICHR is not doing good in the industry: 66.09% of the companies in the same industry are doing better.
  • ICHR has a worse Return On Equity (-7.95%) than 66.96% of its industry peers.
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • With a Gross Margin value of 11.45%, ICHR is not doing good in the industry: 86.09% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ICHR has declined.
  • The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.57%
GM growth 5Y-4.81%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

4

2. ICHR Health Analysis

2.1 Basic Checks

  • ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ICHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 6.33 indicates that ICHR is not in any danger for bankruptcy at the moment.
  • With a Altman-Z score value of 6.33, ICHR perfoms like the industry average, outperforming 57.39% of the companies in the same industry.
  • A Debt/Equity ratio of 0.18 indicates that ICHR is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.18, ICHR is in line with its industry, outperforming 47.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 6.33
ROIC/WACCN/A
WACC12.13%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • ICHR has a Current Ratio of 3.16. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.16, ICHR perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
  • A Quick Ratio of 1.38 indicates that ICHR should not have too much problems paying its short term obligations.
  • The Quick ratio of ICHR (1.38) is worse than 81.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.38
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. ICHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.75% over the past year.
  • ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -37.90% yearly.
  • Looking at the last year, ICHR shows a quite strong growth in Revenue. The Revenue has grown by 11.61% in the last year.
  • ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.72% yearly.
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%

3.2 Future

  • The Earnings Per Share is expected to grow by 94.84% on average over the next years. This is a very strong growth
  • ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.14% yearly.
EPS Next Y401.13%
EPS Next 2Y212.28%
EPS Next 3Y63.75%
EPS Next 5Y94.84%
Revenue Next Year18.49%
Revenue Next 2Y17.78%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

3

4. ICHR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 280.52, which means the current valuation is very expensive for ICHR.
  • The rest of the industry has a similar Price/Earnings ratio as ICHR.
  • Compared to an average S&P500 Price/Earnings ratio of 27.71, ICHR is valued quite expensively.
  • The Price/Forward Earnings ratio is 55.98, which means the current valuation is very expensive for ICHR.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ICHR.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.09, ICHR is valued a bit more expensive.
Industry RankSector Rank
PE 280.52
Fwd PE 55.98
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ICHR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 107.67
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ICHR's earnings are expected to grow with 63.75% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y212.28%
EPS Next 3Y63.75%

0

5. ICHR Dividend Analysis

5.1 Amount

  • ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ICHR Fundamentals: All Metrics, Ratios and Statistics

ICHOR HOLDINGS LTD

NASDAQ:ICHR (4/21/2026, 5:42:29 PM)

After market: 64.62 +0.1 (+0.15%)

64.52

+0.06 (+0.09%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners102.36%
Inst Owner Change0.19%
Ins Owners1.12%
Ins Owner Change11.9%
Market Cap2.24B
Revenue(TTM)947.65M
Net Income(TTM)-52.78M
Analysts81.54
Price Target51.44 (-20.27%)
Short Float %5.22%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.67%
Min EPS beat(2)-42.12%
Max EPS beat(2)117.46%
EPS beat(4)1
Avg EPS beat(4)-14.74%
Min EPS beat(4)-79.27%
Max EPS beat(4)117.46%
EPS beat(8)3
Avg EPS beat(8)-563.34%
EPS beat(12)5
Avg EPS beat(12)-364.79%
EPS beat(16)7
Avg EPS beat(16)-272.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.48%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)-0.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.37%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)-0.11%
PT rev (1m)7.62%
PT rev (3m)111.59%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)123.48%
EPS NY rev (1m)0.89%
EPS NY rev (3m)55.16%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)8.54%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)12.29%
Valuation
Industry RankSector Rank
PE 280.52
Fwd PE 55.98
P/S 2.37
P/FCF N/A
P/OCF 75
P/B 3.38
P/tB 7.78
EV/EBITDA 107.67
EPS(TTM)0.23
EY0.36%
EPS(NY)1.15
Fwd EY1.79%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.86
OCFY1.33%
SpS27.28
BVpS19.11
TBVpS8.29
PEG (NY)0.7
PEG (5Y)N/A
Graham Number9.94459 (-84.59%)
Profitability
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.45%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.57%
GM growth 5Y-4.81%
F-Score3
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 5.58
Cap/Depr 107.95%
Cap/Sales 3.82%
Interest Coverage N/A
Cash Conversion 142.09%
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.38
Altman-Z 6.33
F-Score3
WACC12.13%
ROIC/WACCN/A
Cap/Depr(3y)70.04%
Cap/Depr(5y)74.83%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
EPS Next Y401.13%
EPS Next 2Y212.28%
EPS Next 3Y63.75%
EPS Next 5Y94.84%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%
Revenue Next Year18.49%
Revenue Next 2Y17.78%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%
EBIT growth 1Y-63.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year697.58%
EBIT Next 3Y88.46%
EBIT Next 5Y99.45%
FCF growth 1Y-161.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.2%
OCF growth 3Y-1.69%
OCF growth 5Y-4.82%

ICHOR HOLDINGS LTD / ICHR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


Can you provide the valuation status for ICHOR HOLDINGS LTD?

ChartMill assigns a valuation rating of 3 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


Can you provide the profitability details for ICHOR HOLDINGS LTD?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


Can you provide the financial health for ICHR stock?

The financial health rating of ICHOR HOLDINGS LTD (ICHR) is 4 / 10.


What is the earnings growth outlook for ICHOR HOLDINGS LTD?

The Earnings per Share (EPS) of ICHOR HOLDINGS LTD (ICHR) is expected to grow by 401.13% in the next year.